✦ LIBER ✦

Randomized Comparison of Upstream Tirofiban Versus Downstream High Bolus Dose Tirofiban or Abciximab on Tissue-Level Perfusion and Troponin Release in High-Risk Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions: The EVEREST Trial

✍ Scribed by Leonardo Bolognese; Giovanni Falsini; Francesco Liistro; Paolo Angioli; Kenneth Ducci; Tamara Taddei; Roberto Tarducci; Franco Cosmi; Silvia Baldassarre; Antonio Burali

Book ID: 119265651
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 201 KB
Volume: 47
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2005.11.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sex-specific benefits of sirolimus-eluti

Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial

✍ Giuseppe Ferrante; Patrizia Presbitero; Elena Corrada; Gianluca Campo; Leonardo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 419 KB